Critical Illness Brain Dysfunction and Survivorship (CIBS) Center

E. Wesley Ely, MD, MPH

Ely’s rehabilitation research honored by the US Department of Veterans Affairs

E. Wesley Ely, MD, MPH, has received the Paul B. Magnuson Award for Outstanding Achievement in Rehabilitation Research and Development from the U.S. Department of Veterans Affairs (VA).

NIH-funded trial to determine if immunomodulation can improve brain and cardiovascular dysfunction in Long COVID

Vanderbilt University Medical Center is working with scientists around the U.S. to launch the first Phase III, multicenter, placebo-controlled trial to determine the effect of immunomodulation on Long COVID.

Review explores ICU-related cognitive impact scores

A recent systematic review by Vanderbilt researchers has taken a close look at the cognitive instruments used in long-term outcome studies of survivors of adult critical illness and how those test scores are interpreted.

Reduced exercise capacity in ICU survivors

ICU survivors who have impaired exercise capacity months after discharge may have damaged muscle mitochondria — the energy powerhouses of the cell, Vanderbilt researchers propose.

Jane Storie is one of many patients who are experiencing cognitive impairment after recovering from COVID-19. The long-term complication is also impacting her family — husband, James, daughter, Emily, and son, Andrew.

Team helps patients battle post-COVID cognitive issues

Jane Stories is one of many COVID-19 patients still plagued by debilitating symptoms that include achy muscles, anxiety, depression, panic attacks and cognitive impairment.

Vanderbilt, Zambia researchers find delirium in hospitalized patients linked to mortality, disability in Sub-Saharan Africa

Delirium, a form of acute brain dysfunction, is widespread in critically ill patients in lower resourced hospitals, and the duration of delirium predicted both mortality and disability at six months after discharge, according to a study published in PLOS ONE.